| Lisa Marie Hanson, NP | |
|
4538 W South Jordan Pkwy Unit 110, South Jordan, UT 84009-5852 | |
| (801) 661-6052 | |
| Not Available |
| Full Name | Lisa Marie Hanson |
|---|---|
| Gender | Female |
| Speciality | Family Medicine - Adult Medicine |
| Location | 4538 W South Jordan Pkwy Unit 110, South Jordan, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003530429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 5984518-4405 (Utah) | Primary |
| Entity Name | Mmg Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295392645 PECOS PAC ID: 5991039489 Enrollment ID: O20190703001917 |
News Archive
In a preclinical efficacy trial, the cancer drug paclitaxel (Paxceed)–which exerts its effects by binding to and stabilizing microtubules inside cells–reduced the adverse effects of Alzheimer's disease (AD)-like pathology in a mouse model.
So, using SAS software and statistical procedures, he discovered a much simpler way of calculating a Maximum Weight Limit, which closely corresponds to weight recommendations listed on BMI charts. But, you don't need to calculate or know your BMI, nor do you need a chart or online calculator to figure out your Maximum Weight Limit. Fernandez will present his Maximum Weight Limit calculation at the Nevada Public Health Association Conference, 1:30 p.m., Sept. 22 at the University of Nevada, Reno's Joe Crowley Student Union, Room 423.
One of the great challenges for treating Parkinson's diseases and other neurodegenerative disorders is getting medicine to the right place in the brain.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced the first patient enrolled in MINI-AMI, an FDA prospective, randomized, controlled multi-center study to assess the role of 24-hours of direct unloading of the left ventricle with Impella 2.5 support to reduce infarct size in patients with ST-elevation myocardial infarction (STEMI) without cardiogenic shock.
› Verified 8 days ago
| Entity Name | Option Care Infusion Suites Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164194601 PECOS PAC ID: 5698179125 Enrollment ID: O20211122002842 |
News Archive
In a preclinical efficacy trial, the cancer drug paclitaxel (Paxceed)–which exerts its effects by binding to and stabilizing microtubules inside cells–reduced the adverse effects of Alzheimer's disease (AD)-like pathology in a mouse model.
So, using SAS software and statistical procedures, he discovered a much simpler way of calculating a Maximum Weight Limit, which closely corresponds to weight recommendations listed on BMI charts. But, you don't need to calculate or know your BMI, nor do you need a chart or online calculator to figure out your Maximum Weight Limit. Fernandez will present his Maximum Weight Limit calculation at the Nevada Public Health Association Conference, 1:30 p.m., Sept. 22 at the University of Nevada, Reno's Joe Crowley Student Union, Room 423.
One of the great challenges for treating Parkinson's diseases and other neurodegenerative disorders is getting medicine to the right place in the brain.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced the first patient enrolled in MINI-AMI, an FDA prospective, randomized, controlled multi-center study to assess the role of 24-hours of direct unloading of the left ventricle with Impella 2.5 support to reduce infarct size in patients with ST-elevation myocardial infarction (STEMI) without cardiogenic shock.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Marie Hanson, NP 4538 W South Jordan Pkwy Unit 110, South Jordan, UT 84009-5852 Ph: (801) 661-6052 | Lisa Marie Hanson, NP 4538 W South Jordan Pkwy Unit 110, South Jordan, UT 84009-5852 Ph: (801) 661-6052 |
News Archive
In a preclinical efficacy trial, the cancer drug paclitaxel (Paxceed)–which exerts its effects by binding to and stabilizing microtubules inside cells–reduced the adverse effects of Alzheimer's disease (AD)-like pathology in a mouse model.
So, using SAS software and statistical procedures, he discovered a much simpler way of calculating a Maximum Weight Limit, which closely corresponds to weight recommendations listed on BMI charts. But, you don't need to calculate or know your BMI, nor do you need a chart or online calculator to figure out your Maximum Weight Limit. Fernandez will present his Maximum Weight Limit calculation at the Nevada Public Health Association Conference, 1:30 p.m., Sept. 22 at the University of Nevada, Reno's Joe Crowley Student Union, Room 423.
One of the great challenges for treating Parkinson's diseases and other neurodegenerative disorders is getting medicine to the right place in the brain.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced the first patient enrolled in MINI-AMI, an FDA prospective, randomized, controlled multi-center study to assess the role of 24-hours of direct unloading of the left ventricle with Impella 2.5 support to reduce infarct size in patients with ST-elevation myocardial infarction (STEMI) without cardiogenic shock.
› Verified 8 days ago
Dr. Charles Olin Canfield, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10437 S Jordan Gtwy, South Jordan, UT 84095 Phone: 801-877-0705 Fax: 801-335-5957 | |
Ryan C Jones, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11444 S Redwood Rd, South Jordan, UT 84095 Phone: 801-253-5900 | |
Dr. Joseph Barney Stanford, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5126 W Daybreak Pkwy, South Jordan, UT 84095 Phone: 801-213-4500 | |
Dr. David Gareth Owen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5126 W Daybreak Pkwy, South Jordan, UT 84095 Phone: 801-213-4500 Fax: 801-585-3655 | |
Michelle L Palmer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 W South Jordan Pkwy, Suite 102, South Jordan, UT 84095 Phone: 801-508-3111 Fax: 801-508-3105 | |
Annliza Lachica Piacitelli, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1868 W 9800 S, Ste 100, South Jordan, UT 84095 Phone: 801-433-2873 |